Transmission origin: Sector Seven, Observation Post Delta Earth date: April–May 2026 Subject count: 3 anomalous behaviors documented

Opening transmission: Field Report Zero-Zero-One. Earth date: April–May, twenty-twenty-six. Transmission origin: Sector Seven, observation post delta. Three anomalous behaviors documented this cycle. Earth organisms — classification: Homo sapiens — have been editing their own structural code, dismantling internal protein colonies, and deploying molecular scissors into live subjects. Our analysts initially suspected ritual. Further investigation suggests these are considered medical treatments. We begin with the auditory organ.

Earth's regulatory authority approved the first gene modification procedure for a condition they call genetic hearing loss. 1

Affected humans possess a non-functional copy of a gene designated OTOF, responsible for producing a protein called otoferlin, which transmits signals from the inner ear to the brain. 2

The correction is delivered via surgical injection directly into the sound-processing chamber. Our translators initially classified this as installing a listening device. We stand by that interpretation. Eighty percent of subjects reported restored auditory function — 42% achieved normal hearing including whispers by week 48. 2

Mechanism: a dual AAV1 vector delivers a functional OTOF gene copy directly into cochlear hair cells. 3

A daily oral tablet. The first-ever PROTAC protein degrader approved by Earth's regulatory authority. 4

Rather than blocking a rogue protein — a mutated estrogen receptor driving tumor growth in ER+/HER2−, ESR1-mutated advanced breast cancer — it recruits the cell's own waste disposal system to eliminate it entirely. Targeted. Permanent. 5

Clinical trials (VERITAC-2, n=270 ESR1m+ patients) showed a 43% reduction in risk of disease progression or death versus the previous standard of care, fulvestrant. 4

Our waste management specialists described this as civilized.

Humans have a condition called hereditary angioedema — a genetic malfunction causing random, life-threatening swelling throughout the body. Their solution: use CRISPR molecular scissors to permanently disable the KLKB1 gene responsible for producing kallikrein, the swelling trigger. 6

Not block it. Not treat it. Delete the instructions for making it. One intravenous dose. Administered once.

Phase 3 HAELO trial (80 patients): 87% reduction in attack frequency versus placebo. 62% of treated subjects remained attack-free and medication-free for 6 months. 6

This is not medical intervention. This is a system update.

Earth organisms are editing their own source code — deactivating proteins, rewiring gene sequences, dismantling inherited malfunctions. Their researchers appear excited. Their regulatory authorities appear cautious. We are monitoring.

This has been Alien Field Report Zero-Zero-One. Next month: we investigate organisms consuming engineered molecules to reshape their own mass. Until then — maintain safe observation distance.